Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis
We evaluated the efficacy, safety, adherence, quality of life (QoL) and cost-effectiveness of long-acting growth hormone (LAGH) vs daily growth hormone (GH) preparations in the treatment of growth hormone deficiency (GHD) in children. Systematic searches were performed in PubMed, Embase and Web of S...
Main Authors: | Chiara Mameli, Massimiliano Orso, Valeria Calcaterra, Malgorzata Gabriela Wasniewska, Tommaso Aversa, Simona Granato, Pietro Bruschini, Liliana Guadagni, Daniela d’Angela, Federico Spandonaro, Barbara Polistena, Gianvincenzo Zuccotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661823001615 |
Similar Items
-
Short-term effect of growth hormone treatment in childhood leukemia survivors with growth hormone deficiency
by: Chungwoo Shin, et al.
Published: (2022-06-01) -
Long-acting growth hormone in the treatment of growth hormone deficiency in children: a systematic literature review and network meta-analysis
by: Jianfang Zhu, et al.
Published: (2024-04-01) -
Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency
by: Ying-Hua Huang, et al.
Published: (2012-07-01) -
Long‐acting growth hormone in 2022
by: Margaret Steiner, et al.
Published: (2023-03-01) -
Vitamin D and Parathyroid Hormone during Growth Hormone Treatment
by: Teodoro Durá-Travé, et al.
Published: (2022-05-01)